Michelle Cheung from Queen Mary University of London: Studying Decompensated Cirrhosis Patients After HCV Treatment

A recent study in the United Kingdom looked at the 6-month outcomes of those with hepatitis C cirrhosis on antiviral treatment.

Michelle Cheung, BSc, MBBS, from Queen Mary University of London, discussed the results of this research during the International Liver Congress (EASL 2016) in Barcelona, Spain. As hepatitis C becomes treatable, and even curable in many cases, doctors must still find ways to treat these patients and any potential comorbidities they may develop during their treatment process.